» Authors » Trine Folseraas

Trine Folseraas

Explore the profile of Trine Folseraas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 3606
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fossdal G, Braadland P, Hov J, Husebye E, Folseraas T, Ueland P, et al.
Scand J Gastroenterol . 2025 Jan; 60(2):165-173. PMID: 39764583
Objectives: Indications of mitochondrial dysfunction are commonly seen in liver diseases, but data are scarce in primary sclerosing cholangitis (PSC). Analyzing circulating and liver-resident molecules indirectly reflecting mitochondrial dysfunction, we...
2.
Grimsrud M, Forster M, Goeppert B, Hemmrich-Stanisak G, Sax I, Grzyb K, et al.
Hepatol Commun . 2024 Jul; 8(7). PMID: 38967597
Background: People with primary sclerosing cholangitis (PSC) have a 20% lifetime risk of biliary tract cancer (BTC). Using whole-exome sequencing, we characterized genomic alterations in tissue samples from BTC with...
3.
Poch T, Bahn J, Casar C, Krause J, Evangelakos I, Gilladi H, et al.
Cell Rep Med . 2024 Jun; 5(7):101620. PMID: 38901430
Primary sclerosing cholangitis (PSC) is an immune-mediated liver disease of unknown pathogenesis, with a high risk to develop cirrhosis and malignancies. Functional dysregulation of T cells and association with genetic...
4.
van Keulen A, Buettner S, Olthof P, Klumpen H, Erdmann J, Izquierdo-Sanchez L, et al.
Ann Surg Oncol . 2024 Jun; 31(10):6495-6503. PMID: 38896226
Background: Resection of perihilar cholangiocarcinoma (pCCA) is a complex procedure with a high risk of postoperative mortality and early disease recurrence. The objective of this study was to compare patient...
5.
Wacker E, Uellendahl-Werth F, Bej S, Wolkenhauer O, Vesterhus M, Lieb W, et al.
JHEP Rep . 2024 Feb; 6(2):100988. PMID: 38304234
Background & Aims: Genetic and microbiome studies across patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC) have indicated that UC in PSC is a separate disease entity to...
6.
Helgadottir H, Folseraas T, Kemmerich G, Aabakken L, Jorgensen K, Vesterhus M
Tidsskr Nor Laegeforen . 2023 Nov; 143(17). PMID: 37987062
Primary sclerosing cholangitis is a severe liver disease and a leading cause of liver transplantation in Scandinavia. This clinical review article examines recently revised recommendations on diagnosis, follow-up and treatment...
7.
Yaqub S, Bjork I, Sugulle M, Folseraas T
Lancet . 2023 Aug; 402(10403):e10. PMID: 37633669
No abstract available.
8.
De Muynck K, Heyerick L, De Ponti F, Vanderborght B, Meese T, Van Campenhout S, et al.
Hepatology . 2023 Aug; 79(2):269-288. PMID: 37535809
Background And Aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease for which pharmacological treatment options are currently unavailable. PSC is strongly associated with colitis and a disruption...
9.
Steiert T, Parra G, Gut M, Arnold N, Trotta J, Tonda R, et al.
Nucleic Acids Res . 2023 Jun; 51(14):7143-7162. PMID: 37351572
In the late 19th century, formalin fixation with paraffin-embedding (FFPE) of tissues was developed as a fixation and conservation method and is still used to this day in routine clinical...
10.
Braadland P, Bergquist A, Kummen M, Bossen L, Engesaeter L, Reims H, et al.
J Hepatol . 2023 Jun; 79(4):955-966. PMID: 37328069
Background And Aims: We previously demonstrated that people with primary sclerosing cholangitis (PSC) had reduced gut microbial capacity to produce active vitamin B6 (pyridoxal 5'-phosphate [PLP]), which corresponded to lower...